Amaral Dillan Cunha, Monteiro Mário Luiz Ribeiro, Mora-Paez Denisse J, Pimentel Ana Luiza Machado Ribeiro, Almeida Matheus Mizerani Fernandes de, Chen Jacqueline L, Jacometti Raíza, Alves Milton Ruiz, Guedes Jaime, Louzada Ricardo Noguera
Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Divisão de Oftalmologia e Laboratório de Investigação em Oftalmologia (LIM-33), Faculdade de Medicina, Universidade de São Paulo, São Paulo, SR Brazil.
Einstein (Sao Paulo). 2025 Mar 24;23:eRW1045. doi: 10.31744/einstein_journal/2025RW1045. eCollection 2025.
To compare the effectiveness and safety of phacoviscocanalostomy and phacotrabeculectomy in treating combined glaucoma and cataracts.
A systematic review and meta-analysis were conducted following the PRISMA guidelines. The PubMed, Web of Science, Cochrane, and Embase databases were searched for randomized controlled trials or observational studies comparing phacotrabeculectomy to phacoviscocanalostomy in patients with glaucoma and cataracts. Statistical analysis was used to compare the efficacy (intraocular pressure reduction, mean deviation of the visual field, and failure rates) and safety (general complication rate and rates of hyphema, hypotony, perforation, and intraocular pressure spikes) between the two procedures.
The study included 331 eyes from one randomized controlled trial and two non-randomized controlled trials, with 154 undergoing phacoviscocanalostomy and 177 undergoing phacotrabeculectomy. The results indicated no significant differences in surgical failure rates, mean deviation of the visual field, and intraocular pressure at one, three, six, and twelve months between the phacoviscocanalostomy and phacotrabeculectomy groups. Furthermore, although the overall complication rate between the two procedures showed no difference, the rate of intraocular pressure spikes was higher in patients who underwent phacoviscocanalostomy.
Phacotrabeculectomy and phacoviscocanalostomy are effective treatments for glaucoma and cataracts.Prospero database registration: (www.crd.york.ac.uk/prospero) under ID CRD42024502391.
比较超声乳化小梁切开术和超声乳化小梁切除术治疗青光眼合并白内障的有效性和安全性。
按照PRISMA指南进行系统评价和荟萃分析。检索PubMed、Web of Science、Cochrane和Embase数据库,查找比较青光眼合并白内障患者超声乳化小梁切除术与超声乳化小梁切开术的随机对照试验或观察性研究。采用统计分析比较两种手术的疗效(眼压降低、视野平均偏差和失败率)和安全性(一般并发症发生率以及前房积血、低眼压、穿孔和眼压峰值发生率)。
该研究纳入了来自1项随机对照试验和2项非随机对照试验的331只眼,其中154只眼接受了超声乳化小梁切开术,177只眼接受了超声乳化小梁切除术。结果表明,超声乳化小梁切开术组和超声乳化小梁切除术组在手术失败率、视野平均偏差以及术后1个月、3个月、6个月和12个月的眼压方面无显著差异。此外,虽然两种手术的总体并发症发生率无差异,但接受超声乳化小梁切开术的患者眼压峰值发生率更高。
超声乳化小梁切除术和超声乳化小梁切开术是治疗青光眼合并白内障的有效方法。Prospero数据库注册:(www.crd.york.ac.uk/prospero),标识符为CRD42024502391。